The Neuroprotective Effects of Chalcones from Ashitaba on Cuprizone-induced Demyelination Via Modulation of Brain-derived Neurotrophic Factor and Tumor Necrosis Factor α

Overview

Journal Brain Behav

Specialty Psychology

Date 2023 Jul 5

PMID 37403256

Authors

Soodeh Rowhanirad

Mahnaz Taherianfard

Affiliations

Soon will be listed here.

Abstract

Introduction: Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. However, the limitations of available therapeutic strategies are frustrating, both in terms of their low efficacy and multiple side effects. Previous studies showed that natural compounds such as Chalcones possess neuroprotective effects on neurodegenerative disorders. However, few studies have so far been published on the potential effects of Chalcones on treating demyelinating disease. The present study was designed to investigate the effects of Chalcones from Ashitaba (ChA) on cuprizone-induced noxious changes in the C57BL6 mice model of MS.

Methods: The mice received normal diets (Control group: CNT), or Cuprizone-supplemented diets either without ChA (Cuprizone group: CPZ) or with low or high (300, 600 mg/kg/day) doses of ChA (ChA-treated groups: CPZ+ChA300/600). Brain-derived neurotrophic factor (BDNF) and tumor necrosis factor alpha (TNFα) levels, demyelination scores in the corpus callosum (CC), and cognitive impairment were evaluated using the enzyme-linked immunosorbent assay, histological, and Y-maze tests, respectively.

Results: The findings showed that ChA Co-treatment significantly reduced the extent of demyelination in the CC and the serum and brain levels of TNFα in the ChA-treated groups compared to the CPZ group. Besides, treatment with a higher dose of ChA significantly improved the behavioral responses and BDNF levels in the serum and brain of the CPZ+ChA600 group when compared with the CPZ group.

Conclusion: The present study provided evidence for the neuroprotective effects of ChA on cuprizone-induced demyelination and behavioral dysfunction in C57BL/6 mice, possibly by modulating TNFα secretion and BDNF expression.

Citing Articles

Medicinally Privileged Natural Chalcones: Abundance, Mechanisms of Action, and Clinical Trials.

Villa S, Heckman J, Bandyopadhyay D Int J Mol Sci. 2024; 25(17).

PMID: 39273572 PMC: 11395320. DOI: 10.3390/ijms25179623.

The neuroprotective effects of Chalcones from Ashitaba on cuprizone-induced demyelination via modulation of brain-derived neurotrophic factor and tumor necrosis factor α.

Rowhanirad S, Taherianfard M Brain Behav. 2023; 13(9):e3144.

PMID: 37403256 PMC: 10498084. DOI: 10.1002/brb3.3144.

References

Skripuletz T, Gudi V, Hackstette D, Stangel M . De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol Histopathol. 2011; 26(12):1585-97. DOI: 10.14670/HH-26.1585. View

VonDran M, Singh H, Honeywell J, Dreyfus C . Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion. J Neurosci. 2011; 31(40):14182-90. PMC: 3203635. DOI: 10.1523/JNEUROSCI.6595-10.2011. View

Schmitz T, Chew L . Cytokines and myelination in the central nervous system. ScientificWorldJournal. 2008; 8:1119-47. PMC: 2663591. DOI: 10.1100/tsw.2008.140. View

Pilakka-Kanthikeel S, Atluri V, Sagar V, Saxena S, Nair M . Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study. PLoS One. 2013; 8(4):e62241. PMC: 3639992. DOI: 10.1371/journal.pone.0062241. View

Sandoval V, Sanz-Lamora H, Arias G, Marrero P, Haro D, Relat J . Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral. Nutrients. 2020; 12(8). PMC: 7469047. DOI: 10.3390/nu12082393. View

Lv Y, Qian Y, Ou-Yang A, Fu L . Hydroxysafflor Yellow A Attenuates Neuron Damage by Suppressing the Lipopolysaccharide-Induced TLR4 Pathway in Activated Microglial Cells. Cell Mol Neurobiol. 2016; 36(8):1241-1256. PMC: 11482422. DOI: 10.1007/s10571-015-0322-3. View

Wang H, Li C, Wang H, Mei F, Liu Z, Shen H . Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit. Neurosci Bull. 2013; 29(2):251-9. PMC: 5561883. DOI: 10.1007/s12264-013-1323-1. View

Gingele S, Henkel F, Heckers S, Moellenkamp T, Hummert M, Skripuletz T . Delayed Demyelination and Impaired Remyelination in Aged Mice in the Cuprizone Model. Cells. 2020; 9(4). PMC: 7226973. DOI: 10.3390/cells9040945. View

Liu B, Mao Z, Yin N, Gu Q, Qi Y, Li X . MW‑9, a chalcones derivative bearing heterocyclic moieties, attenuates experimental autoimmune encephalomyelitis via suppressing pathogenic T17 cells. Mol Med Rep. 2022; 26(4). PMC: 9437958. DOI: 10.3892/mmr.2022.12824. View

10.

Taylor L, Gilmore W, Matsushima G . SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination. Brain Pathol. 2008; 19(3):467-79. PMC: 8094717. DOI: 10.1111/j.1750-3639.2008.00230.x. View

11.

Yasuda M, Kawabata K, Miyashita M, Okumura M, Yamamoto N, Takahashi M . Inhibitory effects of 4-hydroxyderricin and xanthoangelol on lipopolysaccharide-induced inflammatory responses in RAW264 macrophages. J Agric Food Chem. 2013; 62(2):462-7. DOI: 10.1021/jf404175t. View

12.

Makinodan M, Yamauchi T, Tatsumi K, Okuda H, Takeda T, Kiuchi K . Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33(6):978-85. DOI: 10.1016/j.pnpbp.2009.05.006. View

13.

Tanaka S, Ide M, Shibutani T, Ohtaki H, Numazawa S, Shioda S . Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J Neurosci Res. 2006; 83(4):557-66. DOI: 10.1002/jnr.20752. View

14.

Ohnogi H, Kudo Y, Tahara K, Sugiyama K, Enoki T, Hayami S . Six new chalcones from Angelica keiskei inducing adiponectin production in 3T3-L1 adipocytes. Biosci Biotechnol Biochem. 2012; 76(5):961-6. DOI: 10.1271/bbb.110976. View

15.

Hibbits N, Pannu R, Wu T, Armstrong R . Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination. ASN Neuro. 2009; 1(3). PMC: 2784600. DOI: 10.1042/AN20090032. View

16.

Hyman C, Hofer M, Barde Y, Juhasz M, Yancopoulos G, Squinto S . BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 1991; 350(6315):230-2. DOI: 10.1038/350230a0. View

17.

Wergeland S, Torkildsen O, Myhr K, Mork S, Bo L . The cuprizone model: regional heterogeneity of pathology. APMIS. 2012; 120(8):648-57. DOI: 10.1111/j.1600-0463.2012.02882.x. View

18.

Mathew B, Mathew G, Ucar G, Baysal I, Suresh J, Kunjumon Vilapurathu J . Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: Synthesis, biochemistry and molecular docking studies. Bioorg Chem. 2015; 62:22-9. DOI: 10.1016/j.bioorg.2015.07.001. View

19.

Lee S, Chiu Y, Yang S, Chen C, Huang C, Lee-Chen G . Novel synthetic chalcone-coumarin hybrid for Aβ aggregation reduction, antioxidation, and neuroprotection. CNS Neurosci Ther. 2019; 24(12):1286-1298. PMC: 6490010. DOI: 10.1111/cns.13058. View

20.

Mohtashami L, Shakeri A, Javadi B . Neuroprotective natural products against experimental autoimmune encephalomyelitis: A review. Neurochem Int. 2019; 129:104516. DOI: 10.1016/j.neuint.2019.104516. View